{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:06:06Z","timestamp":1789556766706,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.jaad.2008.09.032","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T04:33:35Z","timestamp":1245386015000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":175,"title":["Lichen planus\u2013like eruptions: An emerging side effect of tumor necrosis factor-\u03b1 antagonists"],"prefix":"10.1016","volume":"61","author":[{"given":"Adam","family":"Asarch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Masterpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Scheinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel J.","family":"Stadecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Massarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.09.032_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumor necrosis factor-alpha antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.09.032_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2008.09.032_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","article-title":"Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France","volume":"73","author":"Saint Marcoux","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaad.2008.09.032_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.2007.075663","article-title":"Granuloma annulare induced by anti-tumor necrosis factor therapy","volume":"67","author":"Voulgari","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.09.032_bib9","first-page":"69","article-title":"Acneiform eruption following anti-TNF-a treatment: a report of 3 cases","volume":"7","author":"Sun","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000069965","article-title":"Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy","volume":"206","author":"Devos","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2008.09.032_bib11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archderm.138.9.1258","article-title":"Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern","volume":"138","author":"Vergara","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09546630600967174","article-title":"Etanercept-induced lichenoid reaction pattern in psoriasis","volume":"17","author":"Bovenschen","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2008.09.032_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2007.01.014","article-title":"Clinical challenges and images in GI: oral lichenoid reaction in a patient with Crohn's disease receiving infliximab","volume":"132","author":"Moss","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2008.09.032_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1468-3083.2007.02413.x","article-title":"Lichenoid reaction induced by adalimumab","volume":"22","author":"De Simone","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2008.09.032_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0151-9638(07)89187-3","article-title":"Cutaneous manifestations during treatment with TNF-alpha blockers: 11 cases","volume":"134","author":"Lebas","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2008.09.032_bib16","first-page":"188","article-title":"Lichen planus associated with etanercept","volume":"158","author":"Battistella","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib17","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaad.2008.09.032_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555-0193","article-title":"Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis","volume":"87","author":"Seneschal","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2008.09.032_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1345\/aph.1C477","article-title":"Psoriasiform eruption induced by infliximab","volume":"38","author":"Verea","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2008.09.032_bib20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","article-title":"Type I interferon-associated cytotoxic inflammation in lichen planus","volume":"33","author":"Wenzel","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2008.09.032_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000074116","article-title":"Increased serum levels of tumor necrosis factor alpha in lichen planus","volume":"207","author":"Erdem","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2008.09.032_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000372-199306000-00004","article-title":"Lymphocyte and macrophage subsets in active and inactive lesions of lichen planus","volume":"15","author":"Akasu","year":"1993","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2008.09.032_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.0022-202X.2003.22108.x","article-title":"Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus","volume":"122","author":"Carrozzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/09629350410001688530","article-title":"Salivary levels of tumor necrosis factor-alpha in oral lichen planus","volume":"13","author":"Pezelj-Ribaric","year":"2004","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaad.2008.09.032_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1601-0825.2005.01165.x","article-title":"Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone","volume":"12","author":"Rhodus","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.jaad.2008.09.032_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0714.2006.00392.x","article-title":"Expression of TNF-alpha in oral lichen planus treated with fluocinolone acetonide 0.1%","volume":"35","author":"Thongprasom","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jaad.2008.09.032_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00128071-200708020-00010","article-title":"Etanercept for the management of oral lichen planus","volume":"8","author":"Yarom","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archderm.143.2.233","article-title":"The yin and yang of TNF-{alpha} inhibition","volume":"143","author":"Fiorentino","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2006.059261","article-title":"A medical conundrum: onset of psoriasis in patients receiving anti-tumor necrosis factor agents","volume":"65","author":"Ritchlin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.09.032_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2133.2005.06999.x","article-title":"Lichen planus is associated with human herpesvirus type 7 replication and infiltration of plasmacytoid dendritic cells","volume":"154","author":"De Vries","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.09.032_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/path.1699","article-title":"Recruitment of dendritic cells in oral lichen planus","volume":"205","author":"Santoro","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2008.09.032_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1468-3083.2003.00583.x","article-title":"Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis","volume":"17","author":"Pinto","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2008.09.032_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/000155599750010418","article-title":"Lichen planus induced by interferon-alpha-2b therapy in a patient with cutaneous malignant melanoma","volume":"79","author":"Saval","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2008.09.032_bib34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2133.1997.tb01138.x","article-title":"Oropharyngeal lichen planus associated with interferon-alpha treatment for mycosis fungoides: a rare side-effect in the therapy of cutaneous lymphomas","volume":"137","author":"Kutting","year":"1997","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208012127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208012127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:13:36Z","timestamp":1759270416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208012127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0190962208012127"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.09.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1162711.624294","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lichen planus\u2013like eruptions: An emerging side effect of tumor necrosis factor-\u03b1 antagonists","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}